ada guidelines dpp4 and glp 1 2026 Diabetes Treatment Update: vs NICE Insulin Versus Established GLP-1 Receptor

The bottom line: Our findings suggest that GLP-1RA and SGLT2i (and especially SGLT2i with the lowest number needed to treat (NNT) for nearly all study outcomes) may be the preferred glucose-lowering agents for cardiovascular risk reduction in patients at moderate risk for CVD, building on and consistent with existing RCT evidence in the high-risk population. This report highlights potential preference for GLP-1 drugs as a first-line treatment for Type 2 diabetes related to its cardioprotective effect

Clinical support: Are there studies showing measurable effects in humans

A year from now, I want people to stop thinking of Reddit as the place they end up and start thinking of it as the place they go first

While the exact way topiramate works to suppress appetite is unknown, it is believed to affect the brain to increase satiety

But how does topiramate actually work, what are the risks, and how do its weight loss results compare with Wegovy, Zepbound, and other new GLP-1 weight loss medications